BOSTON, Mass.—March 31, 2020—GE (NYSE:GE) announced today the completion of the sale of its BioPharma business to Danaher Corporation (NYSE:DHR) (“Danaher”) for approximately $20 billion of net proceeds. GE Chairman and CEO H. Lawrence Culp, Jr., said, “Completing the sale of BioPharma represents a critical milestone on our multi-year transformation, fortifying our considerable sources to... Read more
GE Healthcare and Ford collaborate to accelerate and scale ventilator production, supporting clinicians in the treatment of COVID-19 patients GE Healthcare provides information to clinicians who are considering the use of anesthesia systems to ventilate COVID-19 patients, following FDA guidance CHICAGO – March 24, 2020 – GE Healthcare today provided two updates on its continued... Read more
CHICAGO – March 19, 2020 – GE Healthcare President & CEO Kieran Murphy today issued the following statement around efforts to address the coronavirus (COVID-19): “GE Healthcare is proud to support customers, governments and the broader healthcare community in the fight against the coronavirus. Our dedicated teams are working around the clock to ensure that... Read more
CHICAGO – March 19, 2020 – GE Healthcare President & CEO Kieran Murphy today issued the following statement around efforts to address the coronavirus (COVID-19): “GE Healthcare is proud to support customers, governments and the broader healthcare community in the fight against the coronavirus https://www.ge.com/news/press-releases/statement-ge-healthcare-president-ceo-efforts-address-coronavirus Read more
Tokyo, Japan and Chicago, US (March 2nd, 2020) – GE Healthcare (Head Office: Chicago, US) today completed the transfer of ownership of its four diagnostic imaging agents in Japan from Daiichi Sankyo Company, Limited (Head Office: Chuo-ku Tokyo; Daiichi Sankyo). Effective immediately, the four imaging agents, previously managed by Daiichi Sankyo, will be owned and... Read more
Vendor-agnostic solution helps hospitals to proactively monitor and mitigate cybersecurity threats through GE Healthcare’s dedicated network of IT and OT security professionals FEBRUARY 20, 2020 – CHICAGO – GE Healthcare today introduced a new cybersecurity service offering that brings together medical device expertise, artificial intelligence and process management tools to help hospital groups in their... Read more
New facility will help alleviate bottlenecks in manufacturing that impact preclinical research December 16, 2019 – GE Healthcare (GEHC) Life Sciences and the University of Massachusetts Medical School (UMMS) have come together to establish a Large Scale Viral Vector Manufacturing Facility. The new facility will provide large quantities of high-quality recombinant adeno-associated virus (AAV) vectors... Read more
The world’s first integrated 3D bioprinter + confocal scanner (BioAssemblyBot + GE IN Cell Analyzer 6500HS) Strategic R&D and distribution partnership aims to advance the field of 3D biofabrication. Printed cells with vascularization would be first step toward more complex biological structures for bone, soft tissue, and organ replacements. The partners will create an integrated... Read more
Buc, France – December 2, 2019 – GE Healthcare and Affidea, the pan-European leader in advanced diagnostic imaging, outpatient and cancer care services, have signed a multi-year agreement to deploy imaging and digital technologies across the Affidea network. GE Healthcare will install 200+ new equipment in Affidea’s network of centers across Europe. The deal includes the... Read more
Software offers customized profile set-up, simplifies process validation, and minimizes variability in cell transduction via spinoculation December 2, 2019 – GE Healthcare Life Sciences continues to build out its flexible solutions across the cell therapy workflow with the commercial availability of SpinOculation C-Pro Protocol Software. Part of the Sepax™ C-Pro Cell Processing System, the software... Read more